C-GLPA

Description

Important Notices:
This product is sold for scientific research purposes only.
Product is provided as a lyophilized (freeze-dried) powder in a sterile vial.
The quantity on the label refers to the total amount of product inside each vial.
Additional lab supplies are required for conducting research such as bacteriostatic water for reconstitution, syringes  & needles to draw from the vials, and alcohol prep pads for sanitizing vial stoppers prior to needle insertion.
Vial appearance, label, seal and cap colors shows photo of an actual vial.

C-GLPA is an investigational peptide designed to benefit those with obesity and type 2 diabetes by promoting significant weight loss and improving metabolic health. It is a synthetic analog of the natural hormone amylin, which works with insulin to regulate appetite, digestion, and blood sugar.   

While effective as a standalone therapy, C-GLPA is primarily studied in combination with the GLP-1 agonist S-GLP1 to maximize its therapeutic effects. 

Primary Benefits:

• Significant weight loss– promotes a feeling of fullness (satiety) and suppresses appetite by acting on the brain, helping to reduce overall calorie intake
• Improved glycemic control: As an amylin analog, C-GLPA helps regulate post-meal blood sugar spikes by slowing down gastric emptying and suppressing glucagon release.
• Enhanced satiety and appetite control: C-GLPA blunts hunger signals and can help reduce food cravings, which are major obstacles to long-term weight management.
• Cardiometabolic improvements: As a result of weight loss and better metabolic regulation, C-GLPA can contribute to improvements in several cardiometabolic markers, such as blood pressure, cholesterol, and triglycerides.
• Addresses hormonal deficiencies: By mimicking amylin, C-GLPA helps restore hormonal balance in people with obesity, who often have deficiencies in these key appetite-regulating hormones.